Voyager Therapeutics, Inc.
VYGR US92915B1061
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -63% | 104% | 40% | -37% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Jorgensen Nathan D. CFO |
4.78 USD |
7,666 Sold |
36,643 USD |
03/10/2025 | 03/10/2025 |
| Ferguson Toby CMO |
3.73 USD |
19,000 Sold |
70,870 USD |
18/08/2025 | 18/08/2025 |
| Ferguson Toby CMO |
3.43 USD |
10,086 Sold |
34,595 USD |
02/04/2025 | 02/04/2025 |
| Sandrock Alfred CEO |
4.24 USD |
11,702 Sold |
49,616 USD |
20/02/2025 | 20/02/2025 |
| Swartz Robin CBO |
4.25 USD |
3,894 Sold |
16,550 USD |
20/02/2025 | 20/02/2025 |
| Carter Todd Alfred CSO |
4.26 USD |
3,305 Sold |
14,079 USD |
20/02/2025 | 20/02/2025 |
| Fahey Sandell Jacquelyn CLO |
4.45 USD |
4,358 Sold |
19,393 USD |
11/02/2025 | 11/02/2025 |
| Swartz Robin CBO |
4.45 USD |
6,950 Sold |
30,928 USD |
11/02/2025 | 11/02/2025 |
| Carter Todd Alfred CSO |
4.45 USD |
5,413 Sold |
24,088 USD |
11/02/2025 | 11/02/2025 |
| Sandrock Alfred CEO |
4.45 USD |
16,644 Sold |
74,066 USD |
11/02/2025 | 11/02/2025 |